Don't follow what others are doing blindly
Read Guide MOTS-c vs Retatrutide: Mitochondrial vs Incretin Research MOTS-c and Retatrutide both appear in metabolic research but represent very different approaches a mitochondrial signalling peptide versus a multi-receptor incretin agonist
Storage Store unopened material according to the stated condition: -20C recommended (research-only)
In a 2019 review, researchers found that BPC-157 was consistently able to repair soft tissue injuries across all the research that they reviewed
Additionally, there has been significant growth and development in technology including Meibography providing the ability to image Meibomian glands, and a plethora of FDA approved medications and treatment modalities including, BlephEx, LipiFlow, TearCare, iLux, autologous serum, amniotic membranes, Meibomian gland probing, and Exosome therapy
Monitor for any adverse reactions